Helios Towers posted a solid set of results for 2025 that showed continued growth in free cash flow and tenancy additions ahead of expectations.

InMode Ltd. , a leading global provider of innovative medical technologies, today announced that its Board of Directors has authorized a new share repurchase program for up to approximately 10% of the ...

Delivered Q4 2025 and FY 2025 revenue of $120.5 million and $500.6 million Expanded Adjusted EBITDA Margin1 to 25.1% in Q4 2025 and 23.4% for FY 2025 Maintained strong ...